1. RNF220 is required for cerebellum development and regulates medulloblastoma progression through epigenetic modulation of Shh signaling
- Author
-
Bin Sun, Xia Zhou, Pengcheng Ma, Tao An, Bingyu Mao, Yan Li, Liang Zhu, Biyu Ren, Longlong Zhang, and Huishan Wang
- Subjects
Proteasome Endopeptidase Complex ,animal structures ,Ubiquitin-Protein Ligases ,Regulator ,GAB1 ,Cytoplasmic Granules ,Epigenesis, Genetic ,03 medical and health sciences ,0302 clinical medicine ,Neural Stem Cells ,Cell Line, Tumor ,Cerebellum ,medicine ,Animals ,Humans ,Hedgehog Proteins ,Epigenetics ,Sonic hedgehog ,Polyubiquitin ,Molecular Biology ,Transcription factor ,Cell Proliferation ,030304 developmental biology ,Mice, Knockout ,Medulloblastoma ,0303 health sciences ,biology ,Lysine ,Polycomb Repressive Complex 2 ,Ubiquitination ,medicine.disease ,Xenograft Model Antitumor Assays ,Ubiquitin ligase ,Cell biology ,Gene Expression Regulation, Neoplastic ,Mice, Inbred C57BL ,PTCH1 ,030220 oncology & carcinogenesis ,Proteolysis ,embryonic structures ,Disease Progression ,biology.protein ,Protein Binding ,Signal Transduction ,Developmental Biology - Abstract
Sonic hedgehog (Shh) signaling is essential for proliferation of cerebellar granule neuron progenitors (CGNPs) and its mis-regulation is linked to various disorders, including the cerebellar cancer medulloblastoma (MB). We recently identified RNF220, a ubiquitin E3 ligase promoting K63-linked polyubiquitylation and nuclear exportation of Gli transcription factors, as an Shh/Gli regulator involved in ventral neural patterning. Here, we report that RNF220 is required for the proliferation of CGNPs and Daoy cells (an Shh-grouped MB cell line), working as a positive regulator of Shh signaling. Mechanistic investigation demonstrated that RNF220 promotes Shh target gene expression by targeting the PRC2 component EED, and alters levels of epigenetic modification marks on Shh target promoters. We provided evidence that RNF220+/-; Ptch1+/- mice showed lower spontaneous MB occurrence compared with Ptch1+/- mice. Furthermore, in human clinical MB samples, RNF220 expression correlated well with that of GAB1, an Shh-group MB marker. Our findings provide new insights into the epigenetic regulation of Shh signaling and identify RNF220 as a potential new diagnostic marker and therapeutic target for Shh-group MB.
- Published
- 2020
- Full Text
- View/download PDF